SCARB1 and breast carcinoma: Finally, using GEO database (GSE21422) and Kaplan‒Meier plotter online web tool revealed that SCARB1 expression was significantly decreased in breast cancer (Fig. 6N), and a high expression of SCARB1 was significantly associated with worse OS, RFS and DMFS for BRCA patients (Supplementary Fig. 6H).